Does the Vagus Nerve Control Inflammation? What the Science Shows

When scientists talk about regulating inflammation, the conversation usually centers on diet, exercise, supplements, or medication. The nervous system rarely comes up. Yet one of the most elegantly designed anti-inflammatory systems in the human body runs not through the blood but through a nerve: the vagus nerve, the longest cranial nerve in the body, which winds from the brainstem down through the neck, chest, and abdomen, touching nearly every major organ along the way.

The idea that the nervous system directly governs inflammation is less than three decades old. It emerged from a series of experiments in the late 1990s and early 2000s that caught immunologists by surprise and opened an entirely new field of research. Understanding what that research actually shows, and where it stops short, is worthwhile for anyone interested in how the body keeps itself in balance.

The Discovery That Changed Neuroimmunology

The cholinergic anti-inflammatory pathway was first formally described by neuroscientist Kevin Tracey and colleagues in a landmark 2002 Nature paper and elaborated in subsequent reviews. The central finding was striking: the efferent vagus nerve carries signals that reach immune cells in tissues and instruct macrophages to stop producing pro-inflammatory cytokines. When researchers electrically stimulated the vagus nerve in animal models of sepsis, TNF-alpha levels dropped sharply and survival improved. When the vagus nerve was cut, the same stimulus caused a far more severe inflammatory cascade.

A 2003 review by Czura, Friedman, and Tracey described this pathway in detail: efferent signals in the vagus nerve provide a direct mechanism for neural regulation of the immune response that is rapid, localized, and integrated, and vagus nerve stimulation in animal models inhibits the release of TNF, HMGB1, and other cytokines, protecting against endotoxemia and ischemia-reperfusion injury (Czura, Friedman, and Tracey, 2003). The pathway works like a reflex: just as pulling your hand from a flame triggers an automatic motor response, the detection of inflammatory signals by the brain can trigger an automatic anti-inflammatory nerve signal in return.

The molecular mechanism runs through a specific receptor on macrophages. At the end of the vagal pathway, acetylcholine released from nerve terminals binds to alpha-7 nicotinic acetylcholine receptors (alpha-7 nAChR) on tissue macrophages. This binding suppresses the NF-kappa-B signaling cascade that would otherwise drive cytokine gene expression. The result is a rapid, localized reduction in TNF-alpha, IL-1-beta, IL-6, and HMGB1 production without fully disabling the immune response. The anti-inflammatory signal is targeted and reversible, which is what you want from a physiological regulator.

Vagal Tone and Circulating Inflammation in Humans

Because directly measuring vagus nerve activity is invasive, researchers use heart rate variability (HRV) as a practical proxy for vagal tone. The vagus nerve's efferent fibers slow the heart, so a heart that varies its rate fluidly between beats reflects a nerve that is actively modulating cardiac output. Higher HRV, especially in the high-frequency band, is taken as a sign of stronger parasympathetic and vagal activity. This has made HRV a useful research tool for studying the vagal-inflammation link without inserting electrodes.

Multiple studies have found that people with higher HRV tend to have lower circulating inflammatory markers. A qualitative review of 13 studies examining HRV, inflammation, and cardiovascular function found that most reported an inverse relationship between parasympathetic tone (inferred from HRV) and inflammatory markers, with correlation coefficients typically in the range of negative 0.2 to negative 0.4, and the relationships held whether HRV was measured over 5 minutes or 24 hours (Haensel et al., 2008).

A larger study using a nationally representative sample added important specificity to this picture. Researchers at UC Davis analyzed 836 midlife adults in the United States and found robust inverse associations between high-frequency HRV and three inflammatory markers: IL-6, CRP, and fibrinogen. Similar associations were observed between low-frequency HRV and both IL-6 and CRP. Importantly, no significant associations were found between HRV and endothelial adhesion molecules, suggesting the cholinergic pathway acts on certain inflammatory molecules more than others rather than suppressing inflammation broadly (Alen et al., 2021). These are observational findings, which means the association does not prove that vagal tone is causing lower CRP, but it is consistent with the mechanistic picture and has been replicated across multiple populations.

What Happens When You Stimulate the Vagus Nerve Directly

If vagal tone tracks with lower inflammation, deliberately stimulating the vagus nerve should reduce it. This logic has motivated a wave of clinical trials using vagus nerve stimulation (VNS) devices in patients with inflammatory conditions. The early results in inflammatory disease are promising, though they come largely from small pilot studies.

In a 12-month pilot study of nine patients with moderate active Crohn's disease, continuous electrical vagus nerve stimulation reduced CRP in six patients and reduced fecal calprotectin (a gut inflammation marker) in five. By the end of the year, five patients were in clinical remission and six in endoscopic remission. The cytokine profile shifted toward a more anti-inflammatory pattern, with reductions in IL-6, IL-23, IL-12, and TNF-alpha. The authors concluded that VNS appeared to have a global modulatory effect on the immune system alongside gut metabolic changes (Sinniger et al., 2020).

In patients with psoriatic arthritis and ankylosing spondylitis, transcutaneous vagus nerve stimulation produced a measurable anti-inflammatory effect. Twenty patients with psoriatic arthritis and 20 with ankylosing spondylitis used a handheld non-invasive vagal stimulator three times daily for five consecutive days. In the psoriatic arthritis group, clinical disease activity decreased and CRP fell by approximately 20 percent. In the ankylosing spondylitis group, reductions in interferon-gamma, IL-8, and IL-10 were observed (Brock et al., 2021).

These findings are encouraging, but it is important to see them in full context. Both studies involved small samples, no placebo controls, and patients who already had elevated inflammation, which gives more room for a measurable reduction. The effect in healthy adults with normal baseline inflammation is likely smaller and harder to detect.

What a Major Meta-Analysis Found

A 2023 systematic review and meta-analysis set out to determine whether the promising animal and small-study data holds up at scale. The analysis pooled 36 studies involving 1,135 participants who received either real VNS or a sham control. The findings were more cautious than the individual studies suggested. While most cytokines were numerically reduced in the VNS groups, the reductions did not reach statistical significance in the primary meta-analyses for either short-term or long-term stimulation for TNF-alpha or IL-6. One notable exception: a subgroup analysis of four long-term studies in patients with acute inflammation found that VNS significantly reduced CRP compared with sham stimulation (Schiweck et al., 2023).

The authors were careful to note that most included studies had poor to fair quality, heterogeneity was high, and the number of studies per disease was too small for disease-specific conclusions. Their overall assessment: while numeric anti-inflammatory effects appear in individual reports, the current evidence does not substantiate the claim that VNS broadly reduces inflammatory cytokines in humans, but there may be genuine benefit during acute inflammatory events. This is a fair summary of where the science stands today: the mechanism is real, the pathway is real, but translating that into reliable measurable effects on cytokines and CRP in diverse human populations remains an active research challenge.

Lifestyle Practices and Vagal Tone

Even without a VNS device, several common lifestyle practices are associated with higher vagal tone, and some of them overlap with approaches that also lower CRP through other mechanisms. This creates a plausible, if not yet precisely quantified, case that improving vagal tone through lifestyle is one pathway by which certain habits reduce inflammation. These are not remedies or treatments, but they are modifiable factors that researchers study in the context of both HRV and inflammatory markers.

Slow, diaphragmatic breathing is the lifestyle intervention with the most direct and consistent effect on vagal tone. Breathing at a rate of roughly five to six breaths per minute, which corresponds to inhalations and exhalations of about five seconds each, substantially increases high-frequency HRV in real time. This is sometimes called resonance frequency breathing or coherent breathing, and the effect on HRV is measurable in healthy adults within a single session. Whether doing this regularly produces sustained reductions in inflammatory markers is a separate question that research has not resolved definitively, but the mechanistic plausibility is strong.

Regular aerobic exercise increases resting HRV over time. People who exercise regularly tend to have higher resting vagal tone than sedentary people, and aerobic fitness is one of the stronger predictors of HRV in population studies. Exercise also lowers CRP through multiple pathways, including reduced visceral fat, improved insulin sensitivity, and direct anti-inflammatory effects of muscle contractions, making it difficult to attribute the CRP reduction specifically to vagal tone. The point is that exercise likely helps through more than one mechanism, and vagal upregulation may be one of them.

Sleep matters for vagal tone just as it does for inflammation broadly. HRV is highest during deep non-REM sleep and drops with sleep deprivation. Poor sleep is also one of the better-established lifestyle drivers of elevated CRP. The vagal pathway offers one plausible explanation for part of this relationship: when sleep impairs vagal tone, the anti-inflammatory brake on cytokine production weakens, and inflammation rises.

Cold exposure, meditation, and social connection have all been linked to HRV increases in various studies, though the evidence base for each is smaller and less consistent. Cold water on the face activates the diving reflex, a classic vagal response. Mindfulness practices appear to shift the autonomic balance toward parasympathetic dominance in some studies. Strong social bonds are associated with higher HRV in observational research. These are not prescriptions, but they are consistent with a broader picture in which reducing perceived threat and supporting recovery shifts the body toward the parasympathetic, pro-vagal state.

Where the Vagus Nerve Fits in the Bigger Picture of Inflammation

It is easy to overclaim when it comes to the vagus nerve because the basic science is so compelling. A nerve that directly suppresses cytokine release sounds like exactly the kind of lever you would want to pull if you were trying to reduce chronic inflammation. And the lever is real. But the size of its effect in healthy people, as opposed to patients with established inflammatory disease and medical-grade VNS devices, is genuinely uncertain. The HRV-to-inflammation correlations in healthy populations are modest, which is consistent with the vagal pathway being one moderating factor among many rather than a master switch.

The most practical implication of this research may be about balance rather than optimization. The autonomic nervous system operates as a seesaw between sympathetic activation (fight-or-flight) and parasympathetic restoration (rest-and-digest). Chronic psychological stress, poor sleep, sedentary behavior, and social isolation all tip the balance toward sympathetic dominance and away from vagal tone. These are also independent drivers of elevated CRP. The picture that emerges is one in which the nervous system and the immune system are far more integrated than the traditional model implied, and chronic stress on the nervous system translates, partly through vagal mechanisms, into measurable inflammatory load.

CRP is a useful lens through which to observe this system. Because it integrates signals from many sources, tracking CRP over time reveals whether the lifestyle inputs you are putting in are actually shifting your inflammatory baseline. If practices that should support vagal tone, such as better sleep, regular movement, or slow breathing exercises, are doing their job, a lower CRP trend over weeks to months is one way that improvement might show up. CRP is a general wellness marker rather than a diagnosis, and any persistent elevation deserves a conversation with a healthcare provider. But as a tool for watching trends and connecting behavior to biology, it is well suited to the question this research opens: does taking better care of your nervous system actually change your inflammatory state over time?

Sources

• Czura CJ, Friedman SG, Tracey KJ. Neural inhibition of inflammation: the cholinergic anti-inflammatory pathway. Journal of Endotoxin Research, 2003;9(6):409-13. pubmed.ncbi.nlm.nih.gov/14733730
• Alen NV, Parenteau AM, Sloan RP, Hostinar CE. Heart Rate Variability and Circulating Inflammatory Markers in Midlife. Brain, Behavior, and Immunity - Health, 2021;15. pubmed.ncbi.nlm.nih.gov/34268499
• Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology, 2008;33(10):1305-12. pubmed.ncbi.nlm.nih.gov/18819754
• Sinniger V, Pellissier S, Fauvelle F, et al. A 12-month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterology and Motility, 2020;32(10):e13911. pubmed.ncbi.nlm.nih.gov/32515156
• Schiweck C, Sausmekat S, Zhao T, et al. No consistent evidence for the anti-inflammatory effect of vagus nerve stimulation in humans: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 2023;116:237-258. pubmed.ncbi.nlm.nih.gov/38070618

Frequently Asked Questions

Does the vagus nerve reduce inflammation?

Yes, in part. The vagus nerve carries a dedicated anti-inflammatory circuit called the cholinergic anti-inflammatory pathway. It uses acetylcholine to suppress pro-inflammatory cytokine production in macrophages, and people with higher vagal tone tend to have lower circulating CRP and IL-6. Electrically stimulating the vagus nerve has reduced CRP in some clinical trials, particularly in patients with established inflammatory conditions, though effects in healthy adults are more modest and less consistent.

What is vagal tone and how does it relate to CRP?

Vagal tone refers to the baseline level of activity in the vagus nerve's parasympathetic fibers. It is commonly estimated using heart rate variability (HRV): a heart that varies its beat-to-beat timing more fluidly reflects a more active vagal influence. Multiple studies have found an inverse relationship between higher HRV and lower levels of inflammatory markers including CRP, IL-6, and fibrinogen, suggesting that stronger vagal tone is associated with lower systemic inflammation.

Can breathing exercises improve vagal tone and lower inflammation?

Slow, diaphragmatic breathing at roughly five to six breaths per minute reliably increases high-frequency HRV in real time, indicating an acute increase in vagal activity. Whether sustained practice produces lasting reductions in inflammatory markers is less well established, but the mechanistic plausibility is strong. Practices such as slow breathing, regular aerobic exercise, and adequate sleep are all associated with higher resting vagal tone and lower inflammatory markers in observational research.

Is vagus nerve stimulation a treatment for inflammation?

Vagus nerve stimulation (VNS) devices are approved for specific medical conditions such as epilepsy and treatment-resistant depression. Small clinical trials have also shown reductions in CRP and cytokines in patients with inflammatory diseases such as Crohn's disease and psoriatic arthritis. However, a 2023 systematic review found that overall meta-analytic evidence for VNS reducing inflammatory cytokines in humans is not yet consistent, and the therapy is not currently approved specifically as an anti-inflammatory treatment. Anyone interested in VNS for medical purposes should discuss it with a qualified healthcare provider.